Curcumin, hemostasis, thrombosis, and coagulation

Area of Science:

• Pharmacology and Herbal Medicine
• Cardiovascular Research
• Hemostasis and Thrombosis

Background:

• Atherothrombotic cardiovascular disease is a leading global cause of mortality.
• Platelet activation and aggregation are critical in hemostasis and thrombosis.
• Herbal medicines offer potential in managing cardiovascular disease progression, affecting coagulation and platelet function.

Purpose of the Study:

• To review existing literature on curcumin's effects on hemostasis, anticoagulation, and fibrinolysis.
• To explore the molecular mechanisms behind curcumin's antiplatelet and anticoagulant activities.
• To discuss the implications of curcumin for cardiovascular disease treatment.

Main Methods:

• Comprehensive literature review of studies on curcumin and its effects on hemostasis and thrombosis.
• Analysis of molecular mechanisms underlying curcumin's antithrombotic properties.
• Synthesis of findings regarding curcumin's therapeutic potential in cardiovascular disease.

Main Results:

• Curcumin exhibits positive activity in hemostasis, anticoagulation, and fibrinolysis.
• Scientific evidence supports curcumin's anti-inflammatory, antioxidant, and cardiovascular protective effects.
• Molecular mechanisms confirm curcumin's antiplatelet and anticoagulant capabilities.

Conclusions:

• Curcumin demonstrates significant potential as a therapeutic agent for cardiovascular disease.
• Its demonstrated effects on blood clotting and platelet function warrant further investigation.
• Curcumin represents a promising natural compound for complementary and alternative medicine in cardiovascular health.